(Q38327768)

2 September 2017

title

Regulation of the angiotensin type-1 receptor by antisense oligonucleotides occurs through an RNase H-type mechanism (English)

1 reference

2 September 2017

Ho SP

1

1 reference

2 September 2017

Bao Y

2

1 reference

2 September 2017

Lesher T

3

1 reference

2 September 2017

Conklin D

4

1 reference

2 September 2017

Sharp D

5

1 reference

2 September 2017

publication date

1 February 1999

1 reference

2 September 2017

published in

Molecular Brain Research

1 reference

2 September 2017

volume

65

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

23-33

1 reference

2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

The ligand binding signatures of the rat AT1A, AT1B and the human AT1 receptors are essentially identical

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Mode of formation and structural features of DNA-cationic liposome complexes used for transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Synthesis and hybridization studies on two complementary nona(2'-O-methyl)ribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Target-specific arrest of mRNA translation by antisense 2'-O-alkyloligoribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900326-X

7 January 2021

10.1016/S0169-328X(98)00326-X

Identifiers

DOI

1 reference

2 September 2017

1 reference